Greystar buys Greenford site for giant PRS scheme

Wednesday, January 27, 2016 | Paul Norman

Greystar Europe Holdings has bought, with an institutional partner, the 26.5 acre site former GlaxoSmithKline site in Greenford, West London for a major purpose built rental housing led scheme.


The site, formerly home to the GlaxoSmithKline and J. Lyons & Co. operations, will comprise mixed use development with a significant focus on rental housing but also including for-sale residential, employment, active retail, amenity, and community uses.

Greystar said that upon completion it will be the largest purpose built rental housing development created in the UK.

The development is part of Greystar’s plans to introduce its multifamily proposition to the UK market.

Greystar is the largest multifamily operator in the US and a large operator of student housing in the UK, and manages over 410,000 residences worldwide.

For entire article, click View More below.
 
Media Resources
View our PRESS KIT
Press Release Archives
  • Wednesday, July 15, 2020
    Mansion Global: The Ultimate Work-From-Home Amenity: Private Office Suite

    Read More

  • Tuesday, June 30, 2020
    Greystar Creates New Leadership Position to Drive Continued Growth of Vertically Integrated Platform Across Europe

    Read More

  • Monday, June 22, 2020
    Ivanhoé Cambridge, Bouwinvest and Greystar Launch Paris Student and Young Professionals Accommodation Venture with €1 Billion Investment Capacity

    Read More

  • Monday, June 15, 2020
    Mexico Business: Multifamily Residences an Area of Opportunity

    Read More

  • Tuesday, June 2, 2020
    Greystar Acquires Property Management Business of Alliance Residential

    Read More

View All Archives